World's Best Scientists 2026 revealed!
Jeffrey R. Marks

Jeffrey R. Marks

D-Index & Metrics

Medicine

D-Index
100
Citations
71308
World Ranking
8102
National Ranking
4202

Jeffrey R. Marks publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jeffrey R. Marks sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 369 publications — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jeffrey R. Marks D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jeffrey R. Marks sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 100 D-Index — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jeffrey R. Marks is affiliated with Duke University in the United States. Their research primarily focuses on cancer biology, with particular emphasis on breast cancer and molecular mechanisms underlying cancer progression and treatment outcomes.

The scientist's recent publications explore various aspects of cancer development and recurrence, especially in breast cancer. Notable papers include:

  • Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma (2022, Cell)
  • Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer (2022, Nature Genetics)
  • Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts (2022, Cancer Cell)
  • RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence (2020, Cell Death and Differentiation)
  • Tumor-associated nonmyelinating Schwann cell-expressed PVT1 promotes pancreatic cancer kynurenine pathway and tumor immune exclusion (2023, Science Advances)

Their coauthors frequently include Lorraine King, Carlo C. Maley, Lauren C. Peres, Robert B. West, and E. Shelley Hwang.

Jeffrey R. Marks has published extensively in the following venues:

  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Epidemiology Biomarkers & Prevention
  • Journal of Clinical Oncology
  • npj Breast Cancer

The scientist's work spans several main fields of study:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Subfields of study include:

  • Cancer Research
  • Molecular Biology
  • Oncology
  • Radiology, Nuclear Medicine and Imaging
  • Genetics

Main topics covered in their research are:

  • Cancer Genomics and Diagnostics
  • Breast Cancer Treatment Studies
  • Single-cell and spatial transcriptomics
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer Cells and Metastasis
  • Ovarian cancer diagnosis and treatment
  • BRCA gene mutations in cancer

Their multidisciplinary approach integrates advanced molecular classification techniques with genomic analysis and imaging methodologies. This combination supports an in-depth understanding of tumor biology, cancer recurrence, and treatment resistance in breast cancer and other cancer types.

Best Publications

  • Comprehensive molecular portraits of human breast tumours

    Daniel C. Koboldt;Robert S. Fulton;Michael D. McLellan;Heather Schmidt

  • The Immune Landscape of Cancer

    Vésteinn Thorsson;David L Gibbs;Scott D Brown;Denise Wolf

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Oncogenic pathway signatures in human cancers as a guide to targeted therapies.

    Andrea H. Bild;Guang Yao;Jeffrey T. Chang;Quanli Wang

  • Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.

    Giovanni Ciriello;Giovanni Ciriello;Michael L. Gatza;Michael L. Gatza;Andrew H. Beck;Matthew D. Wilkerson

  • Predicting the clinical status of human breast cancer by using gene expression profiles.

    Mike West;Carrie Blanchette;Holly Dressman;Erich Huang

  • BRCA1 mutations in primary breast and ovarian carcinomas

    P. Andrew Futreal;Qingyun Liu;Donna Shattuck-Eidens;Charles Cochran

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression

    Carey K. Anders;David S. Hsu;Gloria Broadwater;Chaitanya R. Acharya

  • Patterns of somatic structural variation in human cancer genomes

    Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  • Pathogenic Germline Variants in 10,389 Adult Cancers

    Kuan-Lin Huang;R Jay Mashl;Yige Wu;Deborah I Ritter

  • Retraction: Genomic signatures to guide the use of chemotherapeutics

    Anil Potti;Holly K Dressman;Andrea Bild;Richard F Riedel

  • Compromised HOXA5 function can limit p53 expression in human breast tumours

    Venu Raman;Shelby A. Martensen;David Reisman;Ella Evron

  • Overexpression and Mutation of p53 in Epithelial Ovarian Cancer

    Jeffrey R. Marks;Andrew M. Davidoff;Billie-Jo M. Kerns;P. A. Humphrey

  • Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060))

    Matthew H. Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer

    Anne T. Ferguson;Ella Evron;Christopher B. Umbricht;Tej K. Pandita

  • Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells

    T Baba;T Baba;P A Convery;N Matsumura;N Matsumura;R S Whitaker

Frequent Co-Authors

Andrew Berchuck
Andrew Berchuck Duke University
Joellen M. Schildkraut
Joellen M. Schildkraut University of Virginia
Carlo C. Maley
Carlo C. Maley Arizona State University
Joseph R. Nevins
Joseph R. Nevins Duke University
Robert C. Bast
Robert C. Bast The University of Texas MD Anderson Cancer Center
Joseph Y. Lo
Joseph Y. Lo Duke University
Maciej A. Mazurowski
Maciej A. Mazurowski Duke University
Michael West
Michael West Duke University
Elaine R. Mardis
Elaine R. Mardis The Ohio State University
Matthew Meyerson
Matthew Meyerson Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While studying Medicine in the USA is a rewarding pursuit, there are several related online degree options that open doors to diverse healthcare careers. For those passionate about nutrition and wellness, exploring online nutrition degrees can lead to impactful roles in dietetics, public health, and food science.

If you’re interested in leadership or hospital administration, finding which online healthcare administration programs have cahme accreditation? is essential for ensuring a high-quality education. This accreditation is widely recognized in the healthcare industry and can boost your career prospects.

Registered nurses (RNs) looking to advance their education may consider online rn to bsn programs without clinical requirements. These flexible programs are ideal for busy professionals wanting to enhance their qualifications without additional in-person commitments.

Those aiming for advanced nursing leadership should look into the shortest msn to dnp program. These accelerated options allow licensed nurses to earn a Doctor of Nursing Practice efficiently and move into influential roles in healthcare practice, education, or policy.

Best Scientists Citing Jeffrey R. Marks

Trending Scientists

Recently Published Articles